Ariel Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

Ariel Investments’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-237,992	Closed	-$819K	–	130
2021 Q1	$819K	Sell	237,992 -633,120	-73%	-$1.97M	0.01%	120
2020 Q4	$2.19M	Buy	871,112 +40,020	+5%	+$87.2K	0.02%	119
2020 Q3	$1.75M	Buy	831,092 +171,776	+26%	+$408K	0.03%	127
2020 Q2	$1.48M	Sell	659,316 -210,763	-24%	-$542K	0.02%	134
2020 Q1	$2.2M	Sell	870,079 -95,505	-10%	-$235K	0.04%	131
2019 Q4	$2.54M	Sell	965,584 -60,729	-6%	-$181K	0.03%	129
2019 Q3	$3.69M	Buy	1,026,313 +702,698	+217%	+$2.49M	0.05%	122
2019 Q2	$1.09M	Buy	+323,615	New	+$1.14M	0.01%	144

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ariel Investments's ENZ Position: Q2 2021 in Review

Ariel Investments sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 237,992 shares — an estimated $819K sold.

Ariel Investments first reported a position in ENZ in Q2 2019 and held it in 8 quarters. The position peaked at $3.69M in Q3 2019. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

Ariel Investments reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
Ariel Investments sold 237,992 Enzo Biochem, Inc. shares in Q2 2021, an estimated $819K.
Ariel Investments first reported a position in Enzo Biochem, Inc. in Q2 2019 and held it in 8 quarters.
Ariel Investments's Enzo Biochem, Inc. position peaked at $3.69M in Q3 2019.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on Ariel Investments's 13F filing for Q2 2021, filed 13 Aug 2021.